Analysis of epithelial neoplastic cells at 3 stages of tumor development and normal cells from the main pancreatic duct. Anti-tumor immunity changes over the course of tumor progression. Results provide insight into how and when effective immune surveillance is overcome during cancer progression.
GPL570:
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Citation:
Hiraoka N, Yamazaki-Itoh R, Ino Y, Mizuguchi Y et al. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology 2011 Jan;140(1):310-21. PMID: 20955708
